SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001399529-19-000044
Filing Date
2019-11-07
Accepted
2019-11-07 16:13:27
Documents
67
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q drna-20190930x10q.htm 10-Q 1360636
2 EXHIBIT 10.1 drnaex101.htm EX-10.1 730530
3 EXHIBIT 31.1 drnaex311.htm EX-31.1 7965
4 EXHIBIT 31.2 drnaex312.htm EX-31.2 7945
5 EXHIBIT 32.1 drnaex321.htm EX-32.1 7310
12 dicernadevelopmentpipeline13.jpg GRAPHIC 250947
13 pearleastdicernalease_image1.gif GRAPHIC 65019
  Complete submission text file 0001399529-19-000044.txt   6131785

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT drna-20190930.xml EX-101.INS 813285
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20190930.xsd EX-101.SCH 45206
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20190930_cal.xml EX-101.CAL 68988
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20190930_def.xml EX-101.DEF 158932
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20190930_lab.xml EX-101.LAB 513020
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20190930_pre.xml EX-101.PRE 290039
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 191200489
SIC: 2834 Pharmaceutical Preparations